Fig. 3: Mapping of MOR binding potential to cortical thickness change. | Translational Psychiatry

Fig. 3: Mapping of MOR binding potential to cortical thickness change.

From: Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder – a longitudinal structural magnetic resonance imaging study

Fig. 3

a Curvilinear association between MOR binding potential and the change in cortical thickness (pre-treatment minus on-treatment) across cortical regions in the OUD group. b MOR receptor binding potential map obtained from a large sample (N = 204) [¹¹C]carfentanil positron emission tomographic imaging study (Kantonen et al. [38], NeuroImage). c Unthresholded map of cortical thickness change (pre-treatment minus on-treatment) in the OUD group. OUD opioid use disorder, MOR μ-opioid receptor.

Back to article page